We're #hiring a Field Clinical Engineer.
Magnus Medical
医疗设备制造业
Burlingame，California 4,100 位关注者
We are creating the next generation of neuromodulation technology to improve quality of life rapidly and effectively.
关于我们
Magnus Medical is a privately held medical device company driven to transform lives by restoring mental health. The company is a developer of brain stimulation technology for the treatment of neuropsychiatric disorders. Its first product is the SAINT? Neuromodulation System, granted Breakthrough Device Designation and 510(k) clearance by the U.S. Food & Drug Administration (FDA) in September 2022 for the treatment of major depressive disorder (MDD) in adults who have failed to achieve satisfactory improvement from prior antidepressant medications in the current episode.
- 网站
-
https://www.magnusmed.com
Magnus Medical的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 总部
- Burlingame，California
- 类型
- 私人持股
- 领域
- mental health和brain health
地点
-
主要
获取路线
Old Bayshore Hwy
US，California，Burlingame，94010
Magnus Medical员工
动态
-
Article discusses early differences in lassitude predicts outcomes in Stanford Neuromodulation Therapy for difficult to treat depression: https://lnkd.in/gkPTNt5p
-
-
"Coral Springs residents now have access to a groundbreaking new treatment for severe depression. Neuro Wellness Centers of America – a clinic that has been serving the mental health needs of the community since 2018- has introduced SAINT TMS therapy by Magnus Medical, an innovative approach that many feel is revolutionizing treatment-resistant depression. According to Matthew Lahn, co-founder of Neuro Wellness Centers of America, SAINT represents the next frontier in Transcranial Magnetic Stimulation. Unlike traditional treatments that require six to nine weeks of therapy, SAINT condenses the process into just five days. Patients undergo ten ten-minute treatments daily, with 50 sessions completed weekly." Read full article: https://lnkd.in/gpYaryGR
-
Dr. Mohammed Ahmed, Dr. Nolan Williams, and Dr. Robert Neborsky sit down to discuss their collaboration in treating a mutual patient who received the SAINT? neuromodulation system at Kaizen Brain Center.
-
Study finds that SAINT? has shown preliminary feasibility, safety, tolerability, and efficacy in treating treatment-resistant bipolar I depression in 2-site open-label trial: https://lnkd.in/gFDSdZvZ
-
-
Brandon Bentzley, MD, PhD presented "Magnus Neuromodulation System with Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) as a Personalized Continuation Therapy for Depression: An Open-Label Pilot Trial" during a Symposium chaired by Nolan Williams, MD at the 6th Annual International Brain Stimulation Conference in Kobe, Japan.
-
-
Exciting news! Magnus Medical is officially on #YouTube! Subscribe to our channel for exclusive content, expert insights, and more: https://lnkd.in/g9pTct3p
-
-
We’re excited to share that Kaizen Brain Center successfully hosted a Ribbon-Cutting Ceremony to commemorate the introduction of the FDA-approved SAINT? Neuromodulation System for Treatment-Resistant Major Depression in San Diego! A heartfelt thank you to Dr. Nolan Williams, Associate Professor of Psychiatry and Behavioral Sciences at Stanford University and Director of the Stanford Brain Stimulation Lab, and Dr. Brandon Bentzley, MD, PhD, Co-Founder and Chief Scientific Officer of Magnus Medical, for being part of our open house! Thank you to everyone who joined us for this event, and a special thanks to our patients who shared their inspiring stories about the impact of SAINT Therapy. Learn more about the event and SAINT: https://lnkd.in/gdsD3-s4 #SAINTTherapy?#MentalHealth?#KaizenBrainCenter?#DepressionTreatment?#EventRecap?#Neuromodulation?#SanDiego
-
-
Psychiatric Research Institute's Dr. Amy Grooms talks about the SAINT? neuromodulation system in a recent interview on KTHV-TV, Channel 11. Watch the full interview here: https://lnkd.in/gdd5fmHx UAMS - University of Arkansas for Medical Sciences
-
We're #hiring a Field Clinical Engineer.